MGC Pharmaceuticals has launched on the London Stock Exchange following the successful completion of a £6.5 million capital raise.
The company’s market capitalisation on debut was approximately £33.7 million at an issue price of 1.475 pence per share.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.